Intravenous Fluids in Hospitalised Children

NCT02926989 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 660

Last updated 2019-08-22

No results posted yet for this study

Summary

The main objective of the trial is to evaluate the risk of hypokalemia following administration of a isotonic solution compared to a hypotonic solution in acutely ill hospitalised children, who need intravenous fluid therapy.

Conditions

Interventions

DRUG

Plasmalyte Glucos 50 mg/mL

Solution contains potassium chloride 5 mmol/L and sodium chloride 140 mmol/L.

DRUG

0.45% saline in 5% dextrose

Solution contains potassium chloride 20 mmol/L and sodium chloride 80 mmol/L.

Sponsors & Collaborators

  • Oulu University Hospital

    collaborator OTHER
  • University of Oulu

    lead OTHER

Principal Investigators

  • Terhi Tapiainen, MD · Oulu University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-03
Primary Completion
2019-03-31
Completion
2019-04-15

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926989 on ClinicalTrials.gov